Please assess the completion status of the following clinical trial:

Trial Title: Innovative Approaches for Minor Consent: Consent 2.0

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: OTHER
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 4.0

Eligibility Criteria:
Note: Age limits apply to adolescent participants and to the adolescent children of parent participants.~Adolescent Inclusion Criteria~* Age 14-17 inclusive~* Able to read and speak English~* HIV status is negative or unknown~* Engaged in high-risk sexual activity in the last six months~Adolescent Exclusion Criteria~* Child of a parent already enrolled in the study~Parent Inclusion Criteria~* Able to read and speak English~* Parent or guardian of an adolescent who is between ages 14-17~* The parent/guardian's adolescent's HIV status is either negative or unknown~Parent Exclusion Criteria~* Parent of a child already enrolled in the study

- Gender: ALL
- Minimum Age: 14 Years
- Maximum Age: 17 Years
- Healthy Volunteers: t

Study Arms:
- Adolescents: Consent Condition 1 (Type: ACTIVE_COMPARATOR): Autonomous minor consent
- Adolescents: Consent Condition 2 (Type: ACTIVE_COMPARATOR): Adult permission required
- Adolescents: Consent Condition 3 (Type: ACTIVE_COMPARATOR): Parental permission required
- Parents: Consent Conditions 1-3 (Type: ACTIVE_COMPARATOR): Autonomous minor consent, adult permission required, and parental permission required

Based on this trial design, predict the completion outcome and termination type (if applicable).